Active Sites Display

PROKKA_00538
Sequence length: 1168 aa
3 domain hit(s)
This protein was scanned against CAZyme family profile alignments to identify conserved domains. Each hit below shows a region of the query that aligns to a known CAZyme family. Within each family profile, certain residues are known or predicted to be catalytic — directly involved in the enzyme's chemical reaction. The sequence display compares these critical positions between the query protein and the family consensus:
Match: the query has the expected catalytic residue, suggesting this active site is conserved and likely functional.
Mismatch: the query has a different residue at this position, which may indicate altered activity, a non-functional site, or subfamily variation.
Gap: the catalytic position in the profile has no corresponding residue in the query alignment, suggesting a deletion or truncation in this region.
Match
Mismatch
Gap
Active Site Conservation Analysis
EntryClassNameDomain RangeCoverageConservationCat. SitesMatches
IPR002889CBMCarbohydrate-binding WSC1–107593.5%47.6%156
IPR000514GHGlycoside hydrolase, family 391–1168100%40%11
IPR001329GHGlycoside hydrolase family 56, bee venom hyaluronidase1091–1104100%60%32
Domain coverage (1–1168 aa)
IPR002889 — Carbohydrate-binding WSC (domain 1–1075)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 Query: MDVKEEISTI KQINSEATPI VSLSVTNLDI EVEEGKVYKD SFFIESENKV PIEGYVCTTS DKVETEAERL EGTRQEIPFY FKGKLATAGN TFEGDIVLIT NGGEYNIPYC VKVIHKFVES SGGRISTMEE FVQIYENNRK EAVDIFFLPN FEEVFLQGKP EQKELYHSLM KSRSKSLILE EFLTAAGYKN TSFLDVSQDK LILEEEDSSA QLELLLTQPG YVEGSIYSEK GQIQISRERF SSDDFTDGKL LFNVEKKQNL LNGSDIIHID TVRQDIEISV EWWAKQTALT KEKEKKLYLK KKRAQLMHNY LYFRTGSIAF EDFAEDSGHV LEELSRYTED NEWKLYRMHF FLMEERKEEG KELLELLEKV SQRDEFTPLE ANYFLYLKAM YYRTPEAISK AVSTIREFYE LSEYKAEALW MLIYLDREYV YNKRLQYDTI RQLFEEGNNS SLLYFEACDI LNENPNYMEE LGKFEISIFR WGVRYGYISL SLSYQFARLA LKAKYYNKSI YYIAEKLYGV EPDEQFLQVI CSLLIKGNRT GKEYHEYFRL AVEANLKIIG LNEFFIRSMD FETYDLIPQR VLIYFTYSNS LDYLEKAYLY SNVLRNKEKY EEVYGAYYSK MLPFIEEQLL KGRINEHLAY LYTCFQKEVL EKPDNWKAVC DILFYHKLIC TNPHIIGVYV SCPELGTEKY YPLSGGTGGV EIYNDRAVLY FVDNNEQRYV KDINYQLREF LSPQQFEEEW IRRNLSNRKI LLMESGKMEE NIKEQTLPVL QRIVFNDDFT RWMQVEAVEK MLVYYENHQD KRNLARWLGK IDYSNISTEF RKALMDYYME VGMMEDAFFG IELYGCDIMG AAKILRLASF GAQCYQGKED EATLSLAYAA FIRKKCNKDT LTYLMKHFKG ETAALLEIWE RSKRFGLETA AFERRILEQV MFTGNDTEGV FPVFESFYAT DEGDELIDRY LEYASMKELE SSMELNDFMH MAIGQEIVNG RMENRHSRIH FLYYFAGRED WYDTIKDTAV YIINGFLQEE FYLPVYQAYS QWITFPIHYQ EMTFLTYHGR AGSNVILRYQ IDGEEYSLRE LHLEEVLPGM YVCHMNFFQK DHVKYRLESD GSPVDEGAGL EFETFEYGDG EESRFFTLNH LDSEESSLPE VKDCLLKTFF ADQYMKLL Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········C ·N········ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·······C·· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ···C·C···· ·········· ·····CR··· ·········· ·········· ·········· ·········· ·C········ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··T······C ········Y· ··RDR····· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ········
query > profilegap>C7C110>C35K112>N37C458>C40C864>C57Q866>C59C886>C77N887>R78F932>C82T1053>T92R1060>C93Y1069>Y102G1073>R106E1074>D107E1075>R108
IPR000514 — Glycoside hydrolase, family 39 (domain 1–1168)
Cross-ref: InterPro: IPR000514
GO: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compoundsGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 Query: MDVKEEISTI KQINSEATPI VSLSVTNLDI EVEEGKVYKD SFFIESENKV PIEGYVCTTS DKVETEAERL EGTRQEIPFY FKGKLATAGN TFEGDIVLIT NGGEYNIPYC VKVIHKFVES SGGRISTMEE FVQIYENNRK EAVDIFFLPN FEEVFLQGKP EQKELYHSLM KSRSKSLILE EFLTAAGYKN TSFLDVSQDK LILEEEDSSA QLELLLTQPG YVEGSIYSEK GQIQISRERF SSDDFTDGKL LFNVEKKQNL LNGSDIIHID TVRQDIEISV EWWAKQTALT KEKEKKLYLK KKRAQLMHNY LYFRTGSIAF EDFAEDSGHV LEELSRYTED NEWKLYRMHF FLMEERKEEG KELLELLEKV SQRDEFTPLE ANYFLYLKAM YYRTPEAISK AVSTIREFYE LSEYKAEALW MLIYLDREYV YNKRLQYDTI RQLFEEGNNS SLLYFEACDI LNENPNYMEE LGKFEISIFR WGVRYGYISL SLSYQFARLA LKAKYYNKSI YYIAEKLYGV EPDEQFLQVI CSLLIKGNRT GKEYHEYFRL AVEANLKIIG LNEFFIRSMD FETYDLIPQR VLIYFTYSNS LDYLEKAYLY SNVLRNKEKY EEVYGAYYSK MLPFIEEQLL KGRINEHLAY LYTCFQKEVL EKPDNWKAVC DILFYHKLIC TNPHIIGVYV SCPELGTEKY YPLSGGTGGV EIYNDRAVLY FVDNNEQRYV KDINYQLREF LSPQQFEEEW IRRNLSNRKI LLMESGKMEE NIKEQTLPVL QRIVFNDDFT RWMQVEAVEK MLVYYENHQD KRNLARWLGK IDYSNISTEF RKALMDYYME VGMMEDAFFG IELYGCDIMG AAKILRLASF GAQCYQGKED EATLSLAYAA FIRKKCNKDT LTYLMKHFKG ETAALLEIWE RSKRFGLETA AFERRILEQV MFTGNDTEGV FPVFESFYAT DEGDELIDRY LEYASMKELE SSMELNDFMH MAIGQEIVNG RMENRHSRIH FLYYFAGRED WYDTIKDTAV YIINGFLQEE FYLPVYQAYS QWITFPIHYQ EMTFLTYHGR AGSNVILRYQ IDGEEYSLRE LHLEEVLPGM YVCHMNFFQK DHVKYRLESD GSPVDEGAGL EFETFEYGDG EESRFFTLNH LDSEESSLPE VKDCLLKTFF ADQYMKLL Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··D······· ········
query > profileD1153>D3
IPR001329 — Glycoside hydrolase family 56, bee venom hyaluronidase (domain 1091–1104)
Cross-ref: InterPro: IPR001329
GO: GO:0004415 hyalurononglucosaminidase activityGO:0006952 defense response
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 Query: MDVKEEISTI KQINSEATPI VSLSVTNLDI EVEEGKVYKD SFFIESENKV PIEGYVCTTS DKVETEAERL EGTRQEIPFY FKGKLATAGN TFEGDIVLIT NGGEYNIPYC VKVIHKFVES SGGRISTMEE FVQIYENNRK EAVDIFFLPN FEEVFLQGKP EQKELYHSLM KSRSKSLILE EFLTAAGYKN TSFLDVSQDK LILEEEDSSA QLELLLTQPG YVEGSIYSEK GQIQISRERF SSDDFTDGKL LFNVEKKQNL LNGSDIIHID TVRQDIEISV EWWAKQTALT KEKEKKLYLK KKRAQLMHNY LYFRTGSIAF EDFAEDSGHV LEELSRYTED NEWKLYRMHF FLMEERKEEG KELLELLEKV SQRDEFTPLE ANYFLYLKAM YYRTPEAISK AVSTIREFYE LSEYKAEALW MLIYLDREYV YNKRLQYDTI RQLFEEGNNS SLLYFEACDI LNENPNYMEE LGKFEISIFR WGVRYGYISL SLSYQFARLA LKAKYYNKSI YYIAEKLYGV EPDEQFLQVI CSLLIKGNRT GKEYHEYFRL AVEANLKIIG LNEFFIRSMD FETYDLIPQR VLIYFTYSNS LDYLEKAYLY SNVLRNKEKY EEVYGAYYSK MLPFIEEQLL KGRINEHLAY LYTCFQKEVL EKPDNWKAVC DILFYHKLIC TNPHIIGVYV SCPELGTEKY YPLSGGTGGV EIYNDRAVLY FVDNNEQRYV KDINYQLREF LSPQQFEEEW IRRNLSNRKI LLMESGKMEE NIKEQTLPVL QRIVFNDDFT RWMQVEAVEK MLVYYENHQD KRNLARWLGK IDYSNISTEF RKALMDYYME VGMMEDAFFG IELYGCDIMG AAKILRLASF GAQCYQGKED EATLSLAYAA FIRKKCNKDT LTYLMKHFKG ETAALLEIWE RSKRFGLETA AFERRILEQV MFTGNDTEGV FPVFESFYAT DEGDELIDRY LEYASMKELE SSMELNDFMH MAIGQEIVNG RMENRHSRIH FLYYFAGRED WYDTIKDTAV YIINGFLQEE FYLPVYQAYS QWITFPIHYQ EMTFLTYHGR AGSNVILRYQ IDGEEYSLRE LHLEEVLPGM YVCHMNFFQK DHVKYRLESD GSPVDEGAGL EFETFEYGDG EESRFFTLNH LDSEESSLPE VKDCLLKTFF ADQYMKLL Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··CH······ ·E········ ·········· ·········· ·········· ·········· ·········· ········
query > profileC1093>C3H1094>H4H1102>E12
↑ Top





v1.01 @copyright 2026 UCLA